erythromycin ethylsuccinate has been researched along with Pharyngitis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crow, SD; Dildy, BR; Ginsburg, CM; Lancaster, K; McCracken, GH; Morchower, G; Steinberg, JB | 1 |
| Alvisi, P; Calabri, G; Cocchi, P; Salvi, G; Silenzi, M; Tamburini, M | 1 |
| Aronovitz, GH; Brook, I; Pichichero, ME | 1 |
| Borzani, M; Careddu, P; Conio, F; Dell'Olio, M; Garlaschi, L; Varotto, F | 1 |
| Guthrie, R | 1 |
| Gaines, JK; Hadfield, TL; Melcher, GP; Winn, RE | 1 |
4 trial(s) available for erythromycin ethylsuccinate and Pharyngitis
| Article | Year |
|---|---|
Open-Label, parallel-group, multicenter, randomized study of cefprozil versus erythromycin in children with group A streptococcal pharyngitis/tonsillitis.
Topics: Anti-Bacterial Agents; Cefprozil; Cephalosporins; Child; Child, Preschool; Erythromycin Ethylsuccinate; Female; Humans; Male; Pharyngitis; Prospective Studies; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 2001 |
Clinical and microbiological evaluation of miocamycin activity against group A beta-hemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.
Topics: Child; Child, Preschool; Clinical Trials as Topic; Drug Resistance, Microbial; Erythromycin; Erythromycin Ethylsuccinate; Female; Humans; Infant; Leucomycins; Male; Miocamycin; Penicillins; Pharyngitis; Streptococcus pyogenes | 1989 |
Erythromycin in acute pharyngitis: a comparison of efficacy and patient tolerance of two twice-daily preparations.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Child; Drug Administration Schedule; Erythromycin; Erythromycin Ethylsuccinate; Humans; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tablets, Enteric-Coated | 1988 |
Comparative efficacy and toxicity of roxithromycin and erythromycin ethylsuccinate in the treatment of streptococcal pharyngitis in adults.
Topics: Adolescent; Adult; Aged; Erythromycin; Erythromycin Ethylsuccinate; Female; Humans; Leucomycins; Male; Middle Aged; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1988 |
2 other study(ies) available for erythromycin ethylsuccinate and Pharyngitis
| Article | Year |
|---|---|
Erythromycin therapy for group A streptococcal pharyngitis. Results of a comparative study of the estolate and ethylsuccinate formulations.
Topics: Adolescent; Child; Child, Preschool; Drug Resistance, Microbial; Erythromycin; Erythromycin Estolate; Erythromycin Ethylsuccinate; Female; Humans; Male; Patient Compliance; Pharyngitis; Prospective Studies; Random Allocation; Streptococcal Infections; Streptococcus pyogenes | 1984 |
[Hepatotoxic syndrome caused by erythromycin ethyl succinate].
Topics: Chemical and Drug Induced Liver Injury; Child; Erythromycin; Erythromycin Ethylsuccinate; Humans; Male; Pharyngitis | 1982 |